115 Sansome Street, Suite 310
San Francisco
CA
94104
USA
(415) 875-7880
info@nilethera.com
Product Categories
Related Content
The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), recently ...
May 15, 2012
March 8, 2011 – Nile Therapeutics is pursuing a new indication for cenderitide, formerly CD-NP. The company is looking ...
March 08, 2011August 5, 2009 – Nile Therapeutics Inc. said this week it dosed its first patient in a phase 2 clinical study of its ...
August 05, 2009